243 related articles for article (PubMed ID: 31740444)
21. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
22. USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism.
Melo-Cardenas J; Xu Y; Wei J; Tan C; Kong S; Gao B; Montauti E; Kirsammer G; Licht JD; Yu J; Ji P; Crispino JD; Fang D
Blood; 2018 Jul; 132(4):423-434. PubMed ID: 29844011
[No Abstract] [Full Text] [Related]
23. USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition.
Ding F; Bao C; Tian Y; Xiao H; Wang M; Xie X; Hu F; Mei J
Int J Mol Sci; 2014 Dec; 16(1):307-20. PubMed ID: 25547493
[TBL] [Abstract][Full Text] [Related]
24. Histone Demethylase JMJD1A Promotes Tumor Progression via Activating Snail in Prostate Cancer.
Tang DE; Dai Y; Xu SH
Mol Cancer Res; 2020 May; 18(5):698-708. PubMed ID: 32019811
[TBL] [Abstract][Full Text] [Related]
25. USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity.
Huang X; Zhang Q; Lou Y; Wang J; Zhao X; Wang L; Zhang X; Li S; Zhao Y; Chen Q; Liang T; Bai X
Cancer Immunol Res; 2019 Oct; 7(10):1580-1590. PubMed ID: 31399419
[TBL] [Abstract][Full Text] [Related]
26. Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications.
Li Y; He Y; Chen Y; He Z; Yang F; Xing C
Apoptosis; 2023 Apr; 28(3-4):576-593. PubMed ID: 36695983
[TBL] [Abstract][Full Text] [Related]
27. Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.
Guo J; Zhao J; Fu W; Xu Q; Huang D
Front Immunol; 2022; 13():918314. PubMed ID: 35935969
[TBL] [Abstract][Full Text] [Related]
28. Ubiquitin-specific protease 22 promotes the proliferation, migration and invasion of glioma cells.
Liang J; Zhang XL; Li S; Xie S; Wang WF; Yu RT
Cancer Biomark; 2018; 23(3):381-389. PubMed ID: 30223389
[TBL] [Abstract][Full Text] [Related]
29. The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer.
Xiao Y; Liu S; Li J; Dai W; Tang W; Xiang L; Zhang W; Lin J; Wang J; Wu X; Liu G; Liu Y; Chen Y; Zhu H; Wang Y; Lin Z; Yang Q; Chen T; Sun Y; Li A; Xiong J; Wang J
Cell Oncol (Dordr); 2020 Dec; 43(6):1017-1033. PubMed ID: 32857323
[TBL] [Abstract][Full Text] [Related]
30. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
[TBL] [Abstract][Full Text] [Related]
31. miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of SOCS1 in human prostate cancer.
Shao N; Ma G; Zhang J; Zhu W
BMC Urol; 2018 Mar; 18(1):14. PubMed ID: 29506516
[TBL] [Abstract][Full Text] [Related]
32. PPARδ Elicits Ligand-Independent Repression of Trefoil Factor Family to Limit Prostate Cancer Growth.
Martín-Martín N; Zabala-Letona A; Fernández-Ruiz S; Arreal L; Camacho L; Castillo-Martin M; Cortazar AR; Torrano V; Astobiza I; Zúñiga-García P; Ugalde-Olano A; Loizaga-Iriarte A; Unda M; Valcárcel-Jiménez L; Arruabarrena-Aristorena A; Piva M; Sánchez-Mosquera P; Aransay AM; Gomez-Muñoz A; Barrio R; Sutherland JD; Carracedo A
Cancer Res; 2018 Jan; 78(2):399-409. PubMed ID: 29187400
[TBL] [Abstract][Full Text] [Related]
33. Dietary Fructose Promotes Prostate Cancer Growth.
Carreño DV; Corro NB; Cerda-Infante JF; Echeverría CE; Asencio-Barría CA; Torres-Estay VA; Mayorga-Weber GA; Rojas PA; Véliz LP; Cisternas PA; Montecinos VP; San Francisco IF; Varas-Godoy MA; Sotomayor PC; Castro MA; Nualart FJ; Inestrosa NC; Godoy AS
Cancer Res; 2021 Jun; 81(11):2824-2832. PubMed ID: 33762358
[TBL] [Abstract][Full Text] [Related]
34. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
35. A hormone-DNA repair circuit governs the response to genotoxic insult.
Goodwin JF; Schiewer MJ; Dean JL; Schrecengost RS; de Leeuw R; Han S; Ma T; Den RB; Dicker AP; Feng FY; Knudsen KE
Cancer Discov; 2013 Nov; 3(11):1254-71. PubMed ID: 24027197
[TBL] [Abstract][Full Text] [Related]
36. HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis.
Zhou X; Li Q; He J; Zhong L; Shu F; Xing R; Lv D; Lei B; Wan B; Yang Y; Wu H; Mao X; Zou Y
Oncotarget; 2017 Mar; 8(12):19342-19353. PubMed ID: 28038443
[TBL] [Abstract][Full Text] [Related]
37. Long non‑coding RNA CTBP1‑AS2 upregulates USP22 to promote pancreatic carcinoma progression by sponging miR‑141‑3p.
Zhang M; Ma S; Li X; Yu H; Tan Y; He J; Wei X; Ma J
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039872
[TBL] [Abstract][Full Text] [Related]
38. A Novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells.
Song J; Yu J; Jeong LS; Lee SK
Cancer Lett; 2021 Jan; 497():54-65. PubMed ID: 33075425
[TBL] [Abstract][Full Text] [Related]
39. ZRANB1 enhances stem-cell-like features and accelerates tumor progression by regulating Sox9-mediated USP22/Wnt/β-catenin pathway in colorectal cancer.
Miao D; Wang Y; Jia Y; Tong J; Jiang S; Liu L
Cell Signal; 2022 Feb; 90():110200. PubMed ID: 34798260
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitin specific protease 22 promotes cell proliferation and tumor growth of epithelial ovarian cancer through synergy with transforming growth factor β1.
Ji M; Shi H; Xie Y; Zhao Z; Li S; Chang C; Cheng X; Li Y
Oncol Rep; 2015 Jan; 33(1):133-40. PubMed ID: 25369910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
